Drug · DIN 02230263
APO-CEFACLOR
No: no longer authorized
The company stopped selling it and its DIN was cancelled. A cancellation is most often a business decision; the record does not say why.
Status Cancelled Post Market since December 2, 2019; first marketed January 20, 1997.
- Drug Identification Number (DIN)
- 02230263
- Company (DIN owner)
- Apotex Inc.Toronto, Ontario, Canada
- Schedule
- Prescription
- Dosage form
- Capsule
- Route
- Oral
- Therapeutic class (ATC)
- Cefaclor J01DC04
- Class
- Human
- Record last updated
- June 29, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| CEFACLOR | 250 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- January 17, 1997: NOC 3344New Drug Submission (NDS)
Other DINs named APO-CEFACLOR
- DIN 02230264 · Cancelled Post Market
- DIN 02237500 · Cancelled Post Market
- DIN 02237501 · Cancelled Post Market
- DIN 02237502 · Cancelled Post Market